HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen [Phase 3]
Phase 3 trial evaluating a coated didanosine (ddI EC)–containing HIV treatment regimen versus a typical anti-HIV regimen; the study status i…
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [Phase 3]
A Phase 3 trial comparing Atazanavir and Nelfinavir, each with two NRTIs, in HIV-infected patients who failed prior therapy without a protea…
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit
A completed clinical trial evaluated qualitative and quantitative HIV RNA detection in saliva using the Oragene RNA Kit, reporting findings …
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy [Phase 4]
Phase 4 safety update evaluating Viracept (nelfinavir) 625 mg in HIV-infected pregnant women. The trial was sponsored by Pfizer and has comp…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection [Phase 4]
This Phase 4 clinical trial examines the impact of a non-tenofovir, non-efavirenz HIV regimen on bone density and vitamin D levels in Africa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a as maintenance therapy and its effect on liver disease progression in people co-infect…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [Phase 4]
DART II is a Phase IV study evaluating a three-drug antiretroviral combination in HIV patients who have not previously received antiretrovir…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) [Phase 3]
Phase 3 clinical trial comparing two HIV regimens that include one of two forms of didanosine (ddI) in HIV-infected participants; the study …
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen [Phase 3]
Phase 3 trial evaluating switching HIV-1 infected subjects from twice-daily HAART to a once-daily regimen to assess feasibility and outcomes…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs [NA]
A completed clinical trial comparing two triple-drug regimens in HIV-infected patients who have never received antiretroviral therapy.
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients [NA]
This completed clinical trial compares two dose levels of didanosine used in combination with stavudine in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) [Phase 3]
Phase 3 rollover studies of Zerit (stavudine) extended-release formulations have completed, reporting results in HIV infection and AIDS.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [NA]
DART I is a Phase IV trial evaluating a triple-antiretroviral drug combination in HIV patients who have not previously received antiretrovir…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Study of Lifestyle Modification in HIV Lipodystrophy [NA]
The clinical trial evaluating lifestyle modification for HIV lipodystrophy has completed, sponsored by Massachusetts General Hospital.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy [Phase 3]
A Phase IIIB trial evaluating the effect of switching to atazanavir on serum lipid levels in HIV-infected individuals virologically suppress…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen
Update from a completed clinical trial examining how frequently the I50L resistance mutation appears in HIV patients who fail regimens conta…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight
This clinical trial update evaluates how Nevirapine exposure (AUC) varies with patient weight in individuals with HIV infection.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Study Comparing Two Forms of Didanosine in HIV-infected Patients [Phase 1]
Phase 1 clinical trial comparing two formulations of didanosine in HIV-infected patients. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen [Phase 3]
A Phase 3 trial evaluating a nucleoside-sparing regimen of atazanavir/ritonavir/efavirenz for HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Drug Interaction - Oral Contraceptive [Phase 1]
A Phase 1 clinical trial update reports on a potential drug interaction between an investigational drug and oral contraceptives in HIV infec…
-
CLINICAL_TRIALS withdrawal · 2011-04-14Clinical Trial Update: Atazanavir for HIV Infected Individuals: An Early Access Program
This report states that the Atazanavir Early Access Program for HIV-infected individuals has ended and is no longer available.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [NA]
A small, open-label pilot trial evaluating a combination of stavudine, didanosine, nelfinavir, and hydroxyurea in people with recent HIV inf…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients [Phase 2, Phase 3]
This clinical trial update reports completion of a Phase 2/3 study evaluating adding entecavir to ongoing lamivudine therapy in patients co-…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [NA]
A completed pilot open-label trial evaluating a four-drug HIV regimen (stavudine, didanosine, nelfinavir, and hydroxyurea) in individuals wi…
-
CLINICAL_TRIALS trial_result · 2011-04-13Clinical Trial Update: Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects
This trial update discusses how the Atazanavir 150L mutation influences response to subsequent HIV treatments in HIV-infected subjects.